세계의 트랜스페션 시약 및 장비 시장 : 제품, 방법, 최종 사용자 및 지역별 규모, 점유율, 전망 및 기회 분석(2023-2030년)

Transfection is the process of introducing nucleic acids into eukaryotic cells by non-viral methods. The reagents and equipment used in these procedures are referred to as transfection reagents and equipment. Transfection has become the powerful analytical tool for the study of gene or protein expression in a wide variety of cell types.

Market Dynamics:

Increase in prevalence of chronic diseases, rise in demand for transfection reagents and equipment, increase in focus on the development of novel therapies, and increase in research and development (R&D) is expected to boost growth of the global transfection reagents and equipment market.

For instance, in August 2021, Mirus Bio expanded its TransIT VirusGen platform compliant with good manufacturing practices (GMP) and viral vector manufacturing to support both cell and gene therapy development and process activities and commercial production.

Moreover, in April 2021, BOC Sciences released in-vivo RNA transfection kits in the company's popular in vivo delivery product series, including siRNA in vivo transfection kits and mRNA in vivo transfection kits, suitable for in vivo transfection of siRNA and mRNA, respectively.

Key features of the study:

• This report provides in-depth analysis of the global transfection reagents and equipment market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global transfection reagents and equipment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Qiagen NV, Promega Corporation, Polyplus-transfection SA, Mirus Bio LLC, Merck KgaA, MaxCyte Inc., Lonza Group, Bio-Rad Laboratories Inc., and Thermo Fisher Scientific Inc., among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global transfection reagents and equipment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global transfection reagents and equipment market.

Detailed Segmentation:

• Global Transfection Reagents and Equipment Market, By Product:
  • Reagents
  • Equipment
• Global Transfection Reagents and Equipment Market, By Method:
  • Biochemical Methods
  • Physical Methods
  • Viral Methods
• Global Transfection Reagents and Equipment Market, By End User:
  • Pharmaceutical and Biotechnology Companies
  • Academics and Research Institutes
• Global Transfection Reagents and Equipment Market, By Geography:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Company Profiles:
  • Qiagen NV
  • Promega Corporation
  • Polyplus-transfection SA
  • Mirus Bio LLC
  • Merck KgaA
  • MaxCyte Inc.
  • Lonza Group
  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific Inc.

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product
  • Market Snapshot, By Method
  • Market Snapshot, By End User
  • Market Snapshot, By Geography
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Rise in demand for transfection reagents and equipment
  • High cost and certain limitations of transfection reagents
  • Increase in demand for synthetic genes worldwide
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Transfection Reagents and Equipment Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Transfection Reagents and Equipment Market, By Product, 2017-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017-2030
  • Segment Trends
• Kits and Reagents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Filtration Systems
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Other Products
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global Transfection Reagents and Equipment Market, By Method, 2017-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017-2030
  • Segment Trends
• Biologicals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Medical Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Water Purification
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Air Purification
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

7. Global Transfection Reagents and Equipment Market, By End User, 2017-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017-2030
  • Segment Trends
• Pharmaceutical and Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Contract Research Organisations (CROs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Academic Research Organisations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Medical Device Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

8. Global Transfection Reagents and Equipment Market, By Geography, 2017-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017-2030
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Method, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Method, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Method, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Method, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Middle East & Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Method, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)

9. Competitive Landscape

• Qiagen NV
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Promega Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Polyplus-transfection SA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Mirus Bio LLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck KgaA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• MaxCyte Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Lonza Group
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us